BCYC($271M) has a higher market cap than NRXP($147M). NRXP YTD gains are higher at: 25.461 vs. BCYC (-45.480). NRXP has higher annual earnings (EBITDA): -21.86M vs. BCYC (-183.2M). BCYC has more cash in the bank: 510M vs. NRXP (26.7M). NRXP has less debt than BCYC: NRXP (1.25M) vs BCYC (14.7M). BCYC has higher revenues than NRXP: BCYC (61.2M) vs NRXP (3.39M).

	BCYC	NRXP	BCYC / NRXP
Capitalization	271M	147M	184%
EBITDA	-183.2M	-21.86M	838%
Gain YTD	-45.480	25.461	-179%
P/E Ratio	N/A	0.36	-
Revenue	61.2M	3.39M	1,803%
Total Cash	510M	26.7M	1,910%
Total Debt	14.7M	1.25M	1,180%

FUNDAMENTALS RATINGS

BCYC vs NRXP: Fundamental Ratings

	BCYC	NRXP
OUTLOOK RATING 1..100	56	62
VALUATION overvalued / fair valued / undervalued 1..100	9 Undervalued	52 Fair valued
PROFIT vs RISK RATING 1..100	100	100
SMR RATING 1..100	97	100
PRICE GROWTH RATING 1..100	74	41
P/E GROWTH RATING 1..100	100	90
SEASONALITY SCORE 1..100	n/a	n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (9) in the null industry is somewhat better than the same rating for NRXP (52). This means that BCYC’s stock grew somewhat faster than NRXP’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as NRXP (100). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as NRXP (100). This means that BCYC’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (41) in the null industry is somewhat better than the same rating for BCYC (74). This means that NRXP’s stock grew somewhat faster than BCYC’s over the last 12 months.

NRXP's P/E Growth Rating (90) in the null industry is in the same range as BCYC (100). This means that NRXP’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	BCYC	NRXP
RSI ODDS (%)	N/A	5 days ago 86%
Stochastic ODDS (%)	2 days ago 82%	2 days ago 83%
Momentum ODDS (%)	2 days ago 90%	2 days ago 80%
MACD ODDS (%)	2 days ago 90%	2 days ago 87%
TrendWeek ODDS (%)	2 days ago 87%	2 days ago 88%
TrendMonth ODDS (%)	2 days ago 86%	2 days ago 86%
Advances ODDS (%)	23 days ago 78%	23 days ago 82%
Declines ODDS (%)	3 days ago 89%	4 days ago 89%
BollingerBands ODDS (%)	2 days ago 85%	N/A
Aroon ODDS (%)	2 days ago 87%	N/A

COMPARISON

Comparison

Sep 13, 2026

Stock price -- (BCYC: $3.86 vs. NRXP: $3.40)

Brand notoriety: BCYC and NRXP are both not notable

Both companies represent the Biotechnology industry

Current volume relative to the 65-day Moving Average: BCYC: 213% vs. NRXP: 31%

Market capitalization -- BCYC: $270.87M vs. NRXP: $147.42M

BCYC [@Biotechnology] is valued at $270.87M. NRXP’s [@Biotechnology] market capitalization is $147.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green while NRXP’s FA Score has 0 green FA rating(s).

BCYC’s FA Score: 1 green, 4 red.
NRXP’s FA Score: 0 green, 5 red.

According to our system of comparison, NRXP is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while NRXP’s TA Score has 4 bullish TA indicator(s).

BCYC’s TA Score: 4 bullish, 5 bearish.
NRXP’s TA Score: 4 bullish, 2 bearish.

According to our system of comparison, NRXP is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -10.23% price change this week, while NRXP (@Biotechnology) price change was -2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

NRXP is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

BCYC

Daily Signal:

Gain/Loss:

NRXP

Setup

Daily Signal:

Description

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
CDGIX	15.17	N/A	N/A
Crawford Large Cap Dividend I
IWEDX	15.23	N/A	N/A
Voya Large Cap Value W
CNSIX	28.10	N/A	N/A
Invesco Convertible Securities R5
BRSSX	16.64	N/A	N/A
MFS Blended Research Small Cap Eq R2
FIOOX	22.12	N/A	N/A
Fidelity Series Large Cap Value Index

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

Ticker / NAME	Correlation To BCYC	1D Price Change %
BCYC	100%	+0.78%
DNLI - BCYC	48% Loosely correlated	-1.45%
PCVX - BCYC	48% Loosely correlated	+0.97%
MGTX - BCYC	47% Loosely correlated	-0.47%
BHVN - BCYC	46% Loosely correlated	-0.63%
NGNE - BCYC	46% Loosely correlated	-1.77%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with TAOX. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then TAOX could also see price increases.

Ticker / NAME	Correlation To NRXP	1D Price Change %
NRXP	100%	N/A
TAOX - NRXP	84% Closely correlated	+2.63%
ALLR - NRXP	81% Closely correlated	-2.40%
PALI - NRXP	74% Closely correlated	+2.49%
BCYC - NRXP	33% Poorly correlated	+0.78%
CRBU - NRXP	32% Poorly correlated	-7.30%
More